Cite
HARVARD Citation
Trudel, S. et al. (2018). Targeting B-cell maturation antigen with GSK2857916 antibody–drug conjugate in relapsed or refractory multiple myeloma (BMA117159): a dose escalation and expansion phase 1 trial. Lancet oncology. 19 (12), pp. 1641-1653. [Online].